51 results
PRE 14A
GLYC
GlycoMimetics Inc
22 Mar 24
Preliminary proxy
5:00pm
officer of ImmunoGen, Inc., formerly a publicly held biotechnology company recently acquired by AbbVie, from 2009 until his retirement in 2016. He … , and as an executive officer of its parent company, Sumitomo Pharma Co. Ltd. from 2017 until her retirement in July 2023. Ms. Andrews joined Boston Biomedical in 2013
8-K
EX-10.1
ypsp957nu8wo
20 May 22
Departure of Directors or Certain Officers
1:09pm
8-K
EX-99.2
ynmy66vjc
5 Aug 21
Glycomimetics Reports Highlights and Financial Results
8:01am
8-K
bnbwbczczl
5 Aug 21
Glycomimetics Reports Highlights and Financial Results
8:01am